Sulprostone

Sulprostone

Sulprostone is a synthetic prostaglandin analogue, specifically an analogue of prostaglandin E2 (PGE2). It is primarily used in the field of obstetrics and gynecology for its potent uterotonic properties.

Medical Uses

Sulprostone is utilized for the management of postpartum hemorrhage (PPH), a condition characterized by excessive bleeding following childbirth. It is also employed in the induction of labor and the termination of pregnancy in the second trimester. The drug works by stimulating uterine contractions, which helps in controlling bleeding and facilitating the expulsion of the fetus and placenta.

Mechanism of Action

Sulprostone acts on the prostaglandin E2 receptors, leading to increased intracellular calcium levels in uterine smooth muscle cells. This results in enhanced muscle contractions, which are crucial for its therapeutic effects in obstetric applications.

Administration and Dosage

Sulprostone is typically administered via the intramuscular or intravenous route. The dosage and administration schedule depend on the specific clinical scenario, such as the severity of postpartum hemorrhage or the stage of pregnancy at which labor induction or termination is required.

Side Effects

Common side effects of sulprostone include nausea, vomiting, diarrhea, and fever. In some cases, it may cause hypertension and bronchospasm. Due to its potent uterotonic effects, there is a risk of uterine rupture if not used appropriately.

Contraindications

Sulprostone is contraindicated in patients with a history of hypersensitivity to prostaglandins, those with active cardiovascular disease, and individuals with a history of asthma due to the risk of bronchospasm.

See Also

• Prostaglandin
• Postpartum hemorrhage
• Labor induction
• Pregnancy termination